Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid detection of AAV8 binding antibodies in gene therapy candidates: development of a point-of-care approach.

Gene therapy·2025
Same author

Evaluating and implementing machine learning models for personalised mobile health app recommendations.

PloS one·2025
Same author

A 27-Year Experience With Day Surgery Transurethral Resection of the Prostate.

Cureus·2024
Same author

Closing Gaps in Lifestyle Adherence for Secondary Prevention of Coronary Heart Disease.

The American journal of cardiology·2021
Same author

Rare and unusual case of hepatic and disseminated tuberculosis in an immunocompetent patient.

BMJ case reports·2019
Same author

Type and Duration of Exercise in the SAMMPRIS Trial.

The neurologist·2018

Related Experiment Video

Updated: Jul 17, 2026

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights
07:25

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Published on: October 13, 2023

Sjögren-Larsson syndrome.

Neil Gordon1

  • 1neil-gordon@doctors.org.uk

Developmental Medicine and Child Neurology
|January 27, 2007
PubMed
Summary

Sjögren-Larsson syndrome, a genetic disorder, results from fatty aldehyde dehydrogenase deficiency. This impacts brain and skin, causing ichthyosis, spasticity, and learning issues.

Area of Science:

  • Genetics
  • Biochemistry
  • Neurology

Background:

  • Sjögren-Larsson syndrome is a rare, recessively inherited disorder.
  • It stems from a deficiency in the enzyme fatty aldehyde dehydrogenase (FALDH).
  • Key features include ichthyosis, spastic diplegia, and cognitive impairment.

Purpose of the Study:

  • To describe the clinical manifestations and diagnostic methods for Sjögren-Larsson syndrome.
  • To explore the underlying biochemical defect and its consequences.
  • To discuss diagnostic and prenatal testing options.

Main Methods:

  • Clinical observation and symptom documentation.
  • Neurophysiological tests: sensory evoked potentials, electromyography.
  • Biochemical assays: FALDH activity in fibroblasts, genetic mutation analysis (PCR).

More Related Videos

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Jul 17, 2026

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights
07:25

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights

Published on: October 13, 2023

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

  • Proton magnetic resonance spectroscopy and post-mortem examination.

    • Main Results:

    • Accumulation of lipids in brain regions observed post-mortem.
    • Diagnosis confirmed by measuring FALDH activity and identifying mutations.
    • Prenatal diagnosis is feasible using genetic analysis.
    • The disorder is linked to mutations on chromosome 17.

    Conclusions:

    • FALDH deficiency disrupts fatty aldehyde oxidation, linking neurological and dermatological symptoms.
    • Accurate diagnosis relies on enzyme assays and genetic testing.
    • Multidisciplinary management is essential for affected children.